Organox

Organox company information, Employees & Contact Information

Explore related pages

Related company profiles:

"Living Organs For Life" Transforming transplantation with the OrganOx metra®. A transportable, automated ex vivo liver perfusion device. The core technology employed by the OrganOx metra® has been in development for over 15 years. During this time both of the founders (Professor Peter Friend and Professor Constantin Coussios) have driven the development of organ preservation and maintenance, formerly at the University of Cambridge and latterly at the University of Oxford. OrganOx Limited was founded in April 2008 as a spin-out from the University of Oxford. Conventional cold preservation involves storage of the liver at 4˚C, using a non-physiological perfusion solution that aims to minimise liver decay. By contrast, warm preservation seeks to re-create an environment that mimics the human body by continuously perfusing at physiological pressures and flows with oxygen-carrying red cells at 37˚C and providing nutrition. The liver is therefore functional during the preservation period, producing bile, metabolizing glucose and maintaining a physiological pH. This enables objective assessment of organ performance prior to transplant, extended preservation times, and the potential use of organs that are presently being discarded.

Company Details

Employees
200
Founded
-
Address
Magdalen Centre, Robert Robinson Avenue,united Kingdom
Phone
4401865784156
Email
ma****@****nox.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Oxford, Oxfordshire
Looking for a particular Organox employee's phone or email?

Organox Questions

News

Oxford University spinout OrganOx to be acquired by Terumo for a record $1.5bn - University of Oxford

Oxford University spinout OrganOx to be acquired by Terumo for a record $1.5bn University of Oxford

Terumo to buy OrganOx for $1.5B to enter transplant field - MedTech Dive

Terumo to buy OrganOx for $1.5B to enter transplant field MedTech Dive

Terumo inks $1.5B deal for liver transplant tech developer OrganOx - Fierce Biotech

Terumo inks $1.5B deal for liver transplant tech developer OrganOx Fierce Biotech

Terumo signs agreement to buy OrganOx for $1.5bn - Medical Device Network

Terumo signs agreement to buy OrganOx for $1.5bn Medical Device Network

OrganOx gets FDA green light for liver perfusion during air transport - MassDevice

OrganOx gets FDA green light for liver perfusion during air transport MassDevice

Terumo Buying Organ Tech Provider OrganOx for $1.5 Billion - Bloomberg

Terumo Buying Organ Tech Provider OrganOx for $1.5 Billion Bloomberg

Cautious Optimism - Docwire News

Cautious Optimism Docwire News

BGF sells OrganOx to Terumo Corporation for $1.5bn - pehub.com

BGF sells OrganOx to Terumo Corporation for $1.5bn pehub.com

Terumo Corp. to buy OrganOx for $1.5B - Modern Healthcare News

Terumo Corp. to buy OrganOx for $1.5B Modern Healthcare News

OrganOx secures $142M equity financing for organ technology platform - Mobi Health News

OrganOx secures $142M equity financing for organ technology platform Mobi Health News

OrganOx achieves one of the UK’s largest medtech exit to date, generating record returns for BGF - BeBeez International

OrganOx achieves one of the UK’s largest medtech exit to date, generating record returns for BGF BeBeez International

Oxford medtech spinout OrganOx acquired for $1.5 billion - Med-Tech Insights

Oxford medtech spinout OrganOx acquired for $1.5 billion Med-Tech Insights

Oxford-based OrganOx achieves one of the UK’s largest MedTech exits at $1.5 billion valuation - EU-Startups

Oxford-based OrganOx achieves one of the UK’s largest MedTech exits at $1.5 billion valuation EU-Startups

OrganOx achieves one of UK’s largest medtech exits - BGF

OrganOx achieves one of UK’s largest medtech exits BGF

Oxford University's OrganOx acquired by Terumo for £1.1bn - BBC

Oxford University's OrganOx acquired by Terumo for £1.1bn BBC

OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting - GlobeNewswire

OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting GlobeNewswire

Oxford’s OrganOx is shortlisted for the MacRobert Award 2025 - University of Oxford

Oxford’s OrganOx is shortlisted for the MacRobert Award 2025 University of Oxford

Liver transplant specialist OrganOx raises $142M for tissue support system - Fierce Biotech

Liver transplant specialist OrganOx raises $142M for tissue support system Fierce Biotech

OrganOx raises $142M to support organ transplant tech - MassDevice

OrganOx raises $142M to support organ transplant tech MassDevice

Latham & Watkins Advises OrganOx in US$1.5 Billion Acquisition by Terumo Corporation - Latham & Watkins LLP

Latham & Watkins Advises OrganOx in US$1.5 Billion Acquisition by Terumo Corporation Latham & Watkins LLP

BGF exits Oxford medtech OrganOx in $1.5B deal - Mobi Health News

BGF exits Oxford medtech OrganOx in $1.5B deal Mobi Health News

OrganOx, ProCure partner to expand access to donor liver-preserving tech - Fierce Healthcare

OrganOx, ProCure partner to expand access to donor liver-preserving tech Fierce Healthcare

Organox liver perfusion device cleared by FDA during air transport - BioWorld MedTech

Organox liver perfusion device cleared by FDA during air transport BioWorld MedTech

Oxford’s OrganOx completes $142m equity financing round - Insider Media Ltd

Oxford’s OrganOx completes $142m equity financing round Insider Media Ltd

Terumo to acquire OrganOx for $1.5bn – largest UK university spinout exit - Amadeus Capital Partners

Terumo to acquire OrganOx for $1.5bn – largest UK university spinout exit Amadeus Capital Partners

Oxford University’s transplantation spinout OrganOx acquired by Terumo Corporation in $1.5 billion deal - EdTech Innovation Hub

Oxford University’s transplantation spinout OrganOx acquired by Terumo Corporation in $1.5 billion deal EdTech Innovation Hub

Terumo Buys OrganOx in $1.5B Deal to Expand Organ Transplant Solutions - The Healthcare Technology Report.

Terumo Buys OrganOx in $1.5B Deal to Expand Organ Transplant Solutions The Healthcare Technology Report.

Terumo buys OrganOx in $1.5B deal - Seeking Alpha

Terumo buys OrganOx in $1.5B deal Seeking Alpha

Terumo to acquire OrganOx for $1.5 billion - Healthcare Today

Terumo to acquire OrganOx for $1.5 billion Healthcare Today

Organox raises $142M for liver transplant technology - BioWorld MedTech

Organox raises $142M for liver transplant technology BioWorld MedTech

Oxford’s OrganOx to get acquired by Terumo in $1.5B deal - Silicon Canals

Oxford’s OrganOx to get acquired by Terumo in $1.5B deal Silicon Canals

Terumo to acquire Oxford spin-out OrganOx in $1.5b deal - Pharmafile

Terumo to acquire Oxford spin-out OrganOx in $1.5b deal Pharmafile

Oxford spin-out OrganOx sold to Japanese group for $1.5bn - The Times

Oxford spin-out OrganOx sold to Japanese group for $1.5bn The Times

Terumo buys OrganOx in $1.5bn deal - The Engineer

Terumo buys OrganOx in $1.5bn deal The Engineer

OrganOx wins 2025 MacRobert award for organ preservation tech - The Engineer

OrganOx wins 2025 MacRobert award for organ preservation tech The Engineer

Award-winning OrganOx acquired by global MedTech company for $1.5Bn - Cambridge Network

Award-winning OrganOx acquired by global MedTech company for $1.5Bn Cambridge Network

Oxford spinout OrganOx acquired by Terumo in record $1.5 billion deal - Cherwell

Oxford spinout OrganOx acquired by Terumo in record $1.5 billion deal Cherwell

OrganOx Enrols First US Patient for Post-Approval Study - PR Newswire

OrganOx Enrols First US Patient for Post-Approval Study PR Newswire

Oxford’s OrganOx raises a £25 million profusion to expand its commercial footprint and make transplant organs more widely available - Tech.eu

Oxford’s OrganOx raises a £25 million profusion to expand its commercial footprint and make transplant organs more widely available Tech.eu

Oxford-based MedTech firm OrganOx acquired for £1.2bn - Home | Digital Health

Oxford-based MedTech firm OrganOx acquired for £1.2bn Home | Digital Health

BGF nets 10x MM with €1.3bn OrganOx exit to Terumo - EU.COM

BGF nets 10x MM with €1.3bn OrganOx exit to Terumo EU.COM

MedTech OrganOx sold in £1.1bn deal - BusinessCloud

MedTech OrganOx sold in £1.1bn deal BusinessCloud

Organox raises £25M to fund US expansion, eyes IPO on Nasdaq - BioWorld MedTech

Organox raises £25M to fund US expansion, eyes IPO on Nasdaq BioWorld MedTech

OrganOx completes $142m equity financing round - BGF

OrganOx completes $142m equity financing round BGF

Oxford-based medical device company OrganOx raised €29 million to transform organ transplantation practices - EU-Startups

Oxford-based medical device company OrganOx raised €29 million to transform organ transplantation practices EU-Startups

UK medtech startup OrganOx bag €22.3M as it prepares for a “potential future IPO” - Silicon Canals

UK medtech startup OrganOx bag €22.3M as it prepares for a “potential future IPO” Silicon Canals

OrganOx wins FDA PMA for its donor liver transport device - MassDevice

OrganOx wins FDA PMA for its donor liver transport device MassDevice

OrganOx £25m raise a ‘step in direction’ of future IPO - UKTN

OrganOx £25m raise a ‘step in direction’ of future IPO UKTN

Terumo Expands in Organ Transplant with Acquisition of OrganOx - cointurk finance

Terumo Expands in Organ Transplant with Acquisition of OrganOx cointurk finance

Top Organox Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant